CCRM Nordic Go to content Talk to us What we do Service Overview CMC Support Process and Analytical Development GMP Manufacturing Analytical Services Market and IP Services Company Creation and Financing Who we are Collaboration Labs & Infrastructure News & Knowledge Team Career History Contact +46 730 269 094 [email protected] What we do Service Overview CMC Support Process and Analytical Development GMP Manufacturing Analytical Services Market and IP Services Company Creation and Financing Who we are Collaboration Labs & Infrastructure News & Knowledge Team Career History Contact +46 730 269 094 [email protected] You Create the Future of Advanced Therapies. We Make the Road There Smoother. What we do Making ATMP Development Work, from Day One We help ATMP teams plan, build and accelerate therapy development with expert support and access to the infrastructure, know-how and partners you need. Whether you need single-topic consultation or long-term collaboration, we offer support at every stage. CMC Support CMC is one of the most complex and critical areas of ATMP development, where getting it right means starting early. We help build regulatory-aligned, future-ready CMC strategies to reduce risk and accelerate progress to clinic and market. Process and Analytical Development We develop reproducible, scalable, and GMP-compliant manufacturing processes and analytics for your ATMP. Our work provides a robust foundation for your therapy, ensuring a cost-effective and viable path to the clinic and market. GMP Manufacturing Our purpose-built ATMP production site will combine an innovative facility design with a team dedicated to the rigour and excellence required for GMP operations. Analytical Services Analytical testing is a vital part of ensuring ATMP safety, identity, purity, and consistency. We support early-stage developers with fee-for-service testing today, and will expand to full QC capabilities from Q1 2027. Market and IP Services The commercial viability of your company is critical, even from the preclinical stage. We work with you and our expert collaborators to conduct commercial analyses and build market and IP strategies to set your therapy up for success. Company Creation and Financing We work to transform promising academic discoveries into successful ventures. CCRM Nordic actively scouts innovative technologies to incubate and works on attracting capital to Nordic ATMP companies, ensuring great projects get funded. How to Engage with Us Whether youre an academic team or a company, we offer multiple ways to collaborate. Get in touch to learn how we can support your development journey. Contact information Fee-for-Service No ATMP-related project is too small for us to consider. Let us know what you have in mind and we’ll try to guide you. In-Kind Although we have limited capabilities in this area right now, we’re constantly scoping for interesting technologies that align with our strategic plan. Grants We can either apply as a partner, a service provider or endorse grants. Let us know if you have a grant in mind, otherwise we might have one. What is CCRM Nordic? CCRM Nordic is a not-for-profit organization with the purpose to address bottlenecks in the translation and commercialization of advanced therapy medicinal products (ATMPs). We are based in Gothenburg Sweden, supporting innovators in the Nordics and Europe. Read more Turning Our GMP Facilities Into Reality - Follow the Journey Our state of the art GMP and process development facilities opens in Q2 2027. Want to follow the progress? Read more News & Knowledge See all News 14 August 2026 Events News Upcoming Events & Where to Meet Us Explore our upcoming events to see where the CCRM Nordic team will be attending and how you can conn... Read more 15 July 2026 Events News ATMP Mini-Symposium No. 4 in Oslo: Launching... Fourth ATMP Mini-Symposium will take place in Oslo on September 14th, featuring the launch of ATMP N... Read more 7 July 2026 Publications Paper: Safety assays for quality control of... To help address challenges associated with rapid microbiological testing, we teamed up with Qiagen t... Read more 15 June 2026 Events News Cell & Gene Therapy Investor Forum The CGT Investor Forum, hosted by CCRM Nordic and ATMP Flemmingsberg, will take place on November 30... Read more 29 May 2026 Publications Poster: ActiveMax µBeads as a cell-free off-the-shelf... We’ve teamed up with Acro Biosystems to test if their ActiveMax μBeads can be a good cell-free off-t... Read more 28 May 2026 Publications White paper: A Change to the CTD... Upcoming changes to the CTD framework will reshape how CMC information is structured and managed. Ou... Read more Stay Connected with CCRM Nordic Join our network for exclusive insights, career opportunities, and thought leadership content from Nordic industry experts. 4000+ professionals Direct communication Weekly insights Follow us on Linkedin “Early access to manufacturing capabilities is a main translational driver to bring advanced therapies to the clinic for the benefits of patients. CCRM Nordic will offer key infrastructure and expertise required to expedite and streamline this process.” Catarina Flyborg Senior Advisor, CCRM Board Director Backed and Trusted by Both Private and Public Sector CCRM Nordic is a public-private partnership, backed by well renowned industry leaders, SMEs and the Swedish Innovation Agency Vinnova. Read more What we do Who we are Collaboration News & Knowledge Team Career History Contact CCRM Nordic AB GoCo House, Förändringens Gata 10, 431 53 Mölndal [email protected] Copyright © 2026. All rights reserved. Made by mkmedia Privacy Policy Equality Policy